Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups
- PMID: 31675080
- PMCID: PMC6826640
- DOI: 10.1001/jamanetworkopen.2019.14344
Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups
Abstract
Importance: An increasing prevalence of adult attention-deficit/hyperactivity disorder (ADHD) diagnosis and treatment has been reported in clinical settings and administrative data in the United States. However, there are limited data on recent trends of adult ADHD diagnosis among racial/ethnic subgroups.
Objective: To examine trends, including associated demographic characteristics, psychiatric diagnoses, and negative outcomes, in the prevalence and incidence of adult ADHD diagnosis among 7 racial/ethnic groups during a 10-year period.
Design, setting, and participants: This cohort study investigated trends in the diagnosis of ADHD in adults who identified as African American or black, Native American, Pacific Islander, Latino or Hispanic, non-Hispanic white, Asian American, or other using the Kaiser Permanente Northern California health plan medical records. A total of 5 282 877 adult patients and 867 453 children aged 5 to 11 years who received care at Kaiser Permanente Northern California from January 1, 2007, to December 31, 2016, were included. Data analysis was performed from January 2017 through September 2019.
Exposures: Period of ADHD diagnosis.
Main outcomes and measures: Prevalence and incidence of licensed mental health clinician-diagnosed ADHD in adults and prevalence of licensed mental health clinician-diagnosed ADHD in children aged 5 to 11 years.
Results: Of 5 282 877 adult patients (1 155 790 [21.9%] aged 25-34 years; 2 667 562 [50.5%] women; 2 204 493 [41.7%] white individuals), 59 371 (1.12%) received diagnoses of ADHD. Prevalence increased from 0.43% in 2007 to 0.96% in 2016. Among 867 453 children aged 5 to 11 years (424 449 [48.9%] girls; 260 236 [30.0%] white individuals), prevalence increased from 2.96% in 2007 to 3.74% in 2016. During the study period, annual adult ADHD prevalence increased for every race/ethnicity, but white individuals consistently had the highest prevalence rates (white individuals: 0.67%-1.42%; black individuals: 0.22%-0.69%; Native American individuals: 0.56%-1.14%; Pacific Islander individuals: 0.11%-0.39%; Hispanic or Latino individuals: 0.25%-0.65%; Asian American individuals: 0.11%-0.35%; individuals from other races/ethnicities: 0.29%-0.71%). Incidence of ADHD diagnosis per 10 000 person-years increased from 9.43 in 2007 to 13.49 in 2016. Younger age (eg, >65 years vs 18-24 years: odds ratio [OR], 0.094; 95% CI, 0.088-0.101; P < .001), male sex (women: OR, 0.943; 95% CI, 0.928-0.959; P < .001), white race (eg, Asian patients vs white patients: OR, 0.248; 95% CI, 0.240-0.257; P < .001), being divorced (OR, 1.131; 95% CI, 1.093-1.171; P < .001), being employed (eg, retired vs employed persons: OR, 0.278; 95% CI, 0.267-0.290; P < .001), and having a higher median education level (OR, 2.156; 95% CI, 2.062-2.256; P < .001) were positively associated with odds of ADHD diagnosis. Having an eating disorder (OR, 5.192; 95% CI, 4.926-5.473; P < .001), depressive disorder (OR, 4.118; 95% CI, 4.030-4.207; P < .001), bipolar disorder (OR, 4.722; 95% CI, 4.556-4.894; P < .001), or anxiety disorder (OR, 2.438; 95% CI, 2.385-2.491; P < .001) was associated with higher odds of receiving an ADHD diagnosis. Adults with ADHD had significantly higher odds of frequent health care utilization (OR, 1.303; 95% CI, 1.272-1.334; P < .001) and sexually transmitted infections (OR, 1.289; 95% CI 1.251-1.329; P < .001) compared with adults with no ADHD diagnosis.
Conclusions and relevance: This study confirmed the reported increases in rates of ADHD diagnosis among adults, showing substantially lower rates of detection among minority racial/ethnic subgroups in the United States. Higher odds of negative outcomes reflect the economic and personal consequences that substantiate the need to improve assessment and treatment of ADHD in adults.
Conflict of interest statement
Figures
Similar articles
-
Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth Cohort.JAMA Netw Open. 2021 Mar 1;4(3):e210321. doi: 10.1001/jamanetworkopen.2021.0321. JAMA Netw Open. 2021. PMID: 33646315 Free PMC article.
-
Recent trends in childhood attention-deficit/hyperactivity disorder.JAMA Pediatr. 2013 Mar 1;167(3):282-8. doi: 10.1001/2013.jamapediatrics.401. JAMA Pediatr. 2013. PMID: 23338799
-
Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016.JAMA Netw Open. 2018 Aug 3;1(4):e181471. doi: 10.1001/jamanetworkopen.2018.1471. JAMA Netw Open. 2018. PMID: 30646132 Free PMC article.
-
Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials.JAMA Netw Open. 2021 Feb 1;4(2):e2037640. doi: 10.1001/jamanetworkopen.2020.37640. JAMA Netw Open. 2021. PMID: 33606033 Free PMC article. Review.
-
Contributors to Underdiagnosis of ADHD among Asian Americans: A Narrative Review.J Atten Disord. 2024 Oct;28(12):1499-1519. doi: 10.1177/10870547241264113. Epub 2024 Jul 31. J Atten Disord. 2024. PMID: 39082427 Review.
Cited by
-
Large-scale analysis reveals racial disparities in the prevalence of ADHD and conduct disorders.Sci Rep. 2024 Oct 24;14(1):25123. doi: 10.1038/s41598-024-75954-5. Sci Rep. 2024. PMID: 39448668 Free PMC article.
-
Prevalence of attention-deficit hyperactivity disorder (ADHD): systematic review and meta-analysis.Eur Psychiatry. 2024 Oct 9;67(1):e68. doi: 10.1192/j.eurpsy.2024.1786. Eur Psychiatry. 2024. PMID: 39381949 Free PMC article. Review.
-
Attention deficit hyperactivity disorder diagnoses and prescriptions in UK primary care, 2000-2018: population-based cohort study.BJPsych Open. 2024 Sep 19;10(5):e152. doi: 10.1192/bjo.2024.781. BJPsych Open. 2024. PMID: 39295426 Free PMC article.
-
Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study is the United States.BMC Psychiatry. 2024 Sep 16;24(1):618. doi: 10.1186/s12888-024-05994-8. BMC Psychiatry. 2024. PMID: 39285361 Free PMC article.
-
Effect of ginseng and ginsenosides on attention deficit hyperactivity disorder: A systematic review.J Ginseng Res. 2024 Sep;48(5):437-448. doi: 10.1016/j.jgr.2024.05.006. Epub 2024 May 28. J Ginseng Res. 2024. PMID: 39263306 Free PMC article. Review.
References
-
- Barkley RA. ADHD: Long-term course, adult outcome, and comorbid disorders In: Jensen PS, Cooper JR, eds. Attention Deficit Hyperactivity Disorder: State of the Science: Best Practices Kingston, NJ: Civic Research Institute; 2002. https://psycnet.apa.org/record/2003-00785-004. Accessed September 27, 2019.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
